Xin Lang Cai Jing·2025-09-21 10:13Group 1 - The report details a fatal incident that occurred on June 3 at the Kanglong Chemical (Beijing) New Drug Technology Co., resulting in the deaths of two employees due to asphyxiation [1] - The incident involved a project for an innovative drug DT-818, which is in the IND approval stage and is sensitive to oxygen, requiring strict control of oxygen levels during production [1] - The two deceased employees had significant tenure at the company, with one having worked there for 6 years and the other for 8 years [1] Group 2 - The investigation identified nine responsible individuals, recommending fines based on their level of responsibility, with the main responsible person facing a penalty of 40% of their annual income [2] - Specific recommendations for fines include the China Regional Production Vice President facing a penalty between 20% and 50% of their annual income [2] - The report highlights a lack of adherence to safety protocols by the deceased employees, which contributed to the incident [1][2]